A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 368
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : GM-CSF
Long Form : granulocyte-macrophage CSF
No. Year Title Co-occurring Abbreviation
2019 G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis. CF, CSFs, G-CSF, ROS
2019 Preventive Effect of Lactobacillus fermentum CQPC08 on 4-Nitroquineline-1-Oxide Induced Tongue Cancer in C57BL/6 Mice. Bax, Bcl-2, Bcl-xL, G-CSF, GST-pi, HO-1, Ig, IL, LF-CQPC08, Nrf2, PTEN
2019 Signal Integration and Transcriptional Regulation of the Inflammatory Response Mediated by the GM-/M-CSF Signaling Axis in Human Monocytes. M-CSF
2018 Enriched Cd141+ DCs in the joint are transcriptionally distinct, activated, and contribute to joint pathogenesis. HC, IA
2018 Mathematical Analysis of Cytokine-Induced Differentiation of Granulocyte-Monocyte Progenitor Cells. CSF, G-CSF, GMP, M-CSF, M-MDSC
2018 Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. EMH, HSPCs
2017 A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. BMDCs, ID2, KDR, MDSCs
2017 Cytokine profile in gingival crevicular fluid and plasma of patients with aggressive periodontitis. AgP, G-CSF, GCF, HC, IL, MCP-1, RANTES
2016 Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia. EGF, FGF-basic, HGF, IFN-alpha, IFN-gamma, IL-10, IL-12, IL-13, IL-15, IL-17, IL-1beta, IL-1ra, IL-2, IL-2R, IL-4, IL-6, IL-8, IP-10, MCP-1, MIG, MIP-1alpha, TNF-alpha, VEGF
10  2016 GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes. CSFs, ERK, G-CSF, LPS, LTA, TLR
11  2016 Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats. CSFs, DRG, G-CSF, IL-34, M-CSF, SNI
12  2015 Colony Stimulating Factors 1, 2, 3 and early pregnancy steps: from bench to bedside. CSFs, G-CSF, M-CSF
13  2014 Colony-stimulating factors for chemotherapy-induced febrile neutropenia. CENTRAL, CI, CSFs, G-CSF, HR, RCTs, RR, SMD
14  2013 Colony stimulating factors and myeloid cell biology in health and disease. CSFs, G-CSF, IL
15  2013 CSF-1R inhibition alters macrophage polarization and blocks glioma progression. CSF-1, CSF-1R, GBM, IFN-gamma, TAMs
16  2013 Dysregulated hematopoiesis caused by mammary cancer is associated with epigenetic changes and hox gene expression in hematopoietic cells. G-CSF, PRC2
17  2012 Dynamics of structural transformations of BCG granulomas and expression of TNF-alpha and granulocyte-macrophage CSF by macrophages in vitro. ---
18  2012 Thrombin stimulates synthesis of macrophage colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor by human proximal tubular epithelial cells in culture. CSFs, G-CSF, M-CSF, PTEC
19  2011 GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells. ---
20  2010 The colony-stimulating factors and cancer. CSFs, G-CSF
21  2008 G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia. CML, G-CSF
22  2008 Increased basal phosphorylation of mitogen-activated protein kinases and reduced responsiveness to inflammatory cytokines in neutrophils from patients with rheumatoid arthritis. ERK, G-CSF, PB, RA, SF, TNF-alpha
23  2007 Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta. BMM, OCs, RANKL, TGF-beta
24  2006 Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. CSF
25  2006 In vitro proliferation of axotomized rat facial nucleus-derived activated microglia in an autocrine fashion. axFN, BrdU, CM, FN, M-CSF, PCNA
26  2005 Dysregulation of granulocyte, erythrocyte, and NK cell lineages in Fli-1 gene-targeted mice. Fli-1, G-CSF, NK
27  2005 Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. G-CSF
28  2005 Inorganic arsenite alters macrophage generation from human peripheral blood monocytes. LPS, M-CSF, MHC, ROS
29  2004 Activation of human neutrophils by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha: role of phosphatidylinositol 3-kinase. G-CSF, PI3K, TNF
30  2004 Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. ALL, G-CSF
31  2004 Evaluation of immunotoxic and immunodisruptive effects of inorganic arsenite on human monocytes/macrophages. CSF
32  2004 Regulation of myeloid development and function by colony stimulating factors. CSFs, G-CSF, M-CSF
33  2004 The colony-stimulating factors: use to prevent and treat neutropenia and its complications. CSFs, FN, G-CSF
34  2003 Adult purpura fulminans associated with staphylococcal infection and administration of colony-stimulating factors. DIC, G-CSF, PF
35  2003 Antiapoptotic effect of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and cyclic AMP on human neutrophils: protein synthesis-dependent and protein synthesis-independent mechanisms and the role of the Janus kinase-STAT pathway. cAMP, G-CSF, STAT3
36  2003 Characterization of the growth-inhibitory and apoptosis-inducing activities of a triterpene saponin, securioside B against BAC1.2F5 macrophages. M-CSF
37  2003 Differences between retinal and choroidal microvascular endothelial cells (MVECs) under normal and hypoxic conditions. Ang, M-CSF, MVEC, MVECs, SRPX, VEGF
38  2003 Methotrexate stimulates lung epithelial cells to release inflammatory cell chemotactic activities. G-CSF, IL, LT, MCP
39  2003 No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease. CR, MDS, S-LDH
40  2002 A novel cell line derived from de novo acute myeloblastic leukaemia with trilineage myelodysplasia which proliferates in response to a Notch ligand, Delta-1 protein. AML/TLD, G-CSF
41  2002 Apoptosis of cord blood neutrophils and their response to colony-stimulating factors. CSF, G-CSF
42  2002 Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells. AML, CML, FAB, G-CSF, HGF, IL-3, MC, SCF
43  2002 Granulocyte macrophage colony-stimulating factor: current practice and novel approaches. CSFs
44  2002 Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. G-CSF, IFN, IL, IL-1ra, M-CSF, MCP-1, TNF
45  2001 Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia. AML, BM, CFU, CFU-GM, EPO, G-CSF, IL-6, PBPC, PEG-rHuMGDF, SCF
46  2001 Effect of cytokines on growth and differentiation of leukaemic cells with translocation t(6;9)(p23;q34). AML, G-CSF, IL-3, MDS, SCF
47  2001 Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy. CSF, IL-1, TNF-alpha, TPO
48  2001 Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection. IP-10, M-CSF, MCP-1, Mig, MIP-2
49  2001 Macrophage colony-stimulating factor is expressed in neuron and microglia after focal brain injury. GSA-I-B4, IL-3, NO, NSE
50  2001 Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1beta antisense RNA. AS, G-CSF, IL-1, LPS, TNF-alpha
51  2001 The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. IL-4, M-CSF, TNF-alpha
52  2000 A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes. APC, DC, Flt3L, SCF
53  2000 Effect of cytokines on the proliferation/differentiation of stroma-initiating cells. IL, M-CSF, TNF
54  2000 Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. CT, DEX, IL-11, M-CSF, OPG, PGE2, PTHrP, RANKL, TGF-beta, TNF-alpha, TRAP
55  2000 Megakaryopoiesis in vitro in myelodysplastic syndromes and acute myeloid leukaemia: effect of pegylated recombinant human megakaryocyte growth and development factor in combination with other growth factors. AML, G-CSF, IL-3, MDS, PEG-rHuMGDF, SCF
56  2000 Neutrophilia associated with anaplastic carcinoma of the thyroid: production of macrophage colony-stimulating factor (M-CSF) and interleukin-6. G-CSF, IL-1alpha, M-CSF, M-CSF, TNF-alpha
57  2000 Proliferation of a subpopulation of human peripheral blood monocytes in the presence of colony stimulating factors may contribute to the inflammatory process in diseases such as rheumatoid arthritis. CSFs
58  2000 Release of GM-CSF and G-CSF by human arterial and venous smooth muscle cells: differential regulation by COX-2. COX-2, CSF, G-CSF
59  1999 Characterization of a CSF-induced proliferating subpopulation of human peripheral blood monocytes by surface marker expression and cytokine production. ---
60  1999 Colony stimulating factors regulate nitric oxide and prostaglandin E2 production in rat cartilage chondrocytes. CSFs, G-CSF, IL-3, M-CSF, PGE2
61  1999 Colony-stimulating factors in rapid eye movement sleep and non-rapid eye movement sleep regulation. CSF, M-CSF, NO, REM
62  1999 Constitutive secretion of hematopoietic cytokines by human carcinoma cell lines and its up-regulation by interleukin-1 and phorbol ester. CM, ELISA, G-CSF, IFN-c, IL-1, LPS, M-CSF, TPA
63  1999 Differential responses of human monocytes and macrophages to IL-4 and IL-13. IL-4, LPS, M-CSF
64  1999 Direct comparison of the effects of CSF-1 (M-CSF) and GM-CSF on human monocyte DNA synthesis and CSF receptor expression. CSF-1R
65  1999 Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. BmDC, CD40L
66  1999 Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. CSF, G-CSF, GRO-alpha, IL-1, M-CSF, MCP-1, TNF-alpha
67  1999 IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. IRS2, MAP, PDE3, PI3K, PKC
68  1999 Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease. G-CSF, IBD, PMN
69  1999 Interleukin-6 and transforming growth factor-beta regulate the expression of monocyte chemoattractant protein-1 and colony-stimulating factors in human thyroid follicular cells. CSFs, IL-6, M-CSF, MCP-1, sIL-6R, TFC, TGF-beta
70  1999 Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils. ---
71  1999 Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. BMMs, LDL, oxLDL
72  1998 A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells. G-CSF, PBPCs
73  1998 Activation of STAT5 by lipopolysaccharide through granulocyte-macrophage colony-stimulating factor production in human monocytes. COX-2, DEX
74  1998 Bladder carcinoma cell line KU-19-19-derived cytokines support proliferation of growth factor-dependent hematopoietic cell lines: modulation by phorbol ester, interferon-gamma and interleukin-1 beta. CM, G-CSF, M-CSF, SCF
75  1998 Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. MMPs, TIMPs
76  1998 Fluid shear stress increases the production of granulocyte-macrophage colony-stimulating factor by endothelial cells via mRNA stabilization. CSFs, HUVECs
77  1998 Glucocorticoids dose-dependently increase plasma levels of granulocyte colony stimulating factor in man. ---
78  1998 Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. ---
79  1998 Myeloid development is selectively disrupted in PU.1 null mice. G-CSF, IL-3, M-CSF, SCF
80  1998 Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma. CSF, ELISA
81  1998 Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. CIA
82  1998 Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1. G-CSF, IL-3
83  1998 Selective inhibition of IL-5 receptor alpha-chain gene transcription by IL-5, IL-3, and granulocyte-macrophage colony-stimulating factor in human blood eosinophils. ---
84  1998 Short-term and long-term cytokine release by mouse bone marrow mast cells and the differentiated KU-812 cell line are inhibited by brefeldin A. BFA, mBMMC
85  1998 The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29. ADCC, IFN-alpha, IL-2, M-CSF, mAb, TNF-alpha
86  1998 The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. IBD, IEC
87  1998 The role of Ets-1 in mast cell granulocyte-macrophage colony-stimulating factor expression and activation. ---
88  1998 Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. AML, BFU-E, CFU-GM, EPO, FCS, G-CSF, IL-3, MDS, SCF, TPO
89  1998 Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. MIP-2
90  1998 Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules. AML, CML, ERK, G-CSF, IL-3, PMA, STAT, TNF, TPO
91  1997 A model system in haematology and immunology: the human monocytic cell line MONO-MAC-1. G-CSF, IL-1beta, LPS, M-CSF, TPA
92  1997 Adhesion and migration are differentially regulated in hematopoietic progenitor cells by cytokines and extracellular matrix. ECM, FDCP, FN, G-CSF, IL-3, LAM, M-CSF, SCF
93  1997 Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages. ---
94  1997 Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. ---
95  1997 Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia. AML, CFU-C, CFU-E, G-CSF, IL-3
96  1997 Ex vivo culture of peripheral blood CD34+ cells: effects of hematopoietic growth factors on production of neutrophilic precursors. G-CSF, HGF, IL, SCF
97  1997 Generation and characterization of a microglial cell line, MG5, derived from a p53-deficient mouse. IL-3, M-CSF, MHC
98  1997 Granulocyte-macrophage colony-stimulating factor regulates the functional adhesive state of very late antigen-4 expressed by eosinophils. CS-1, VCAM, VLA-4
99  1997 In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. DC
100  1997 Increased neutrophil respiratory burst in myeloproliferative disorders: selective enhancement of superoxide release triggered by receptor-mediated agonists and low responsiveness to in vitro cytokine stimulation. CMML, G-CSF, MPDs, TNF